Response
We thank Dr Cheng for his interest in our article showing that atrioventricular (AV) conduction remains stable during the long-term follow-up of patients with sick sinus syndrome who were treated with single chamber atrial (AAI) pacing. 1 We are familiar with the older studies cited by Dr Cheng in which abnormalities in AV conduction can be seen using invasive techniques in a large proportion of patients with sick sinus syndrome. However, none of these abnormalities has been found to predict clinically important AV block in patients with sick sinus syndrome and, as a consequence, routine invasive electrophysiological testing is not recommended anywhere today before pacemaker implantation in these patients. Our results confirm the finding of a 0.6% annual risk of high-grade AV block that was determined in a meta-analysis of 28 studies on AAI pacing in sick sinus syndrome. 2 Therefore, the risk of high-grade AV block requiring an upgrade of the AAI pacemaker is Ͻ1% per year if patients with sick sinus syndrome are selected carefully by using the following clinical criteria: no grade 2 or 3 AV block, a surface ECG PQ interval Յ0.22 s in patients Յ70 years and a PQ interval Յ0.26 s in patients Ͼ70 years, no bundle branch block, and 1:1 AV conduction during atrial pacing at 100 bpm. 1, 3 As long as dual-chamber pacing has not been proven to be clearly superior to single-chamber ventricular (VVI) pacing in these patients, 4 AAI pacing should be the first treatment choice for patients with sick sinus syndrome who have normal AV conduction. 5 
